{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:42:17Z","timestamp":1787164937027,"version":"3.56.0"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1013247","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000}}],"reference-count":146,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Amino acid infusion (AAI) is a technique used in radiopharmaceutical therapy (RPT) to reduce toxicity in kidney and increase clearance rate of radiopharmaceuticals from body. In this study our aim is to evaluate its effect in personalized RPT considering kidney and salivary glands as dose limiting organs using a multiscale modeling framework. We developed a Physiologically-Based Pharmacokinetic (PBPK) model consisting of 19 compartments, personalized it for four prostate cancer patients using data derived from gamma camera imaging. This model was used to investigate the influence of AAI on the absorbed dose to tumors and organs at risk. We then computed the maximum safe injected activity based on the PBPK model. To address the effects of interstitial fluid pressure (IFP) and tumor heterogeneity, we coupled the PBPK model with convection-diffusion-reaction (CDR) equations. To compare the effectiveness of our modeling approaches, we calculated absorbed doses to the tumors with and without AAI, using both the standalone PBPK model and the coupled PBPK-CDR model. Our findings revealed a relative error (RE) of 9.6%\u2009\u00b1\u20092.2% (mean\u2009\u00b1\u2009SD) in total tumor absorbed dose calculation between PBPK and CDR equations, attributable to the consideration of IFP. Moreover, AAI proved beneficial for RPT when the kidney was designated as the organ-at-risk. It enabled an increase in radiopharmaceutical injection from 12.3\u2009\u00b1\u20096.32 MBq (mean\u2009\u00b1\u2009SD) to 15.45\u2009\u00b1\u20096.95 MBq (RE: 28.5%\u2009\u00b1\u200915.7%), resulting in a corresponding increase in tumor absorbed dose from 67.8\u2009\u00b1\u200947.45 Gy to 72.43\u2009\u00b1\u200951.03 Gy (RE: 8.6%\u2009\u00b1\u20095.4%), while maintaining critical kidney absorbed dose limits. However, this was not observed when the salivary gland was considered the dose-limiting organ. Although, AAI allowed for increased therapeutic injection ranging from 4.22\u2009\u00b1\u20092.23 MBq to 5.25\u2009\u00b1\u20093.14 MBq (RE: 19.2%\u2009\u00b1\u20099.9%), it results in a minimal increase in tumor absorbed dose of 0.22\u2009\u00b1\u20090.04 (RE: 1.4%\u2009\u00b1\u20091.3%). Statistical analysis using the Wilcoxon Signed-Rank Test revealed significant effects of AAI on administered activity and tumor absorbed dose (p-value\u2009=\u20090.007\u2009&lt;\u20090.05). Finally, a local sensitivity analysis was performed on selected radiation and tumor transportation parameters individually to evaluate their impact on the tumor absorbed dose. In conclusion, selection of organ-at-risk in personalized RPT is critical, as it determines the injected activity amount and the efficacy of delivery-enhancing techniques.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1013247","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T17:43:42Z","timestamp":1752687822000},"page":"e1013247","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multi-scale computational modeling towards efficacy in radiopharmaceutical therapies while minimizing side effects: Modeling of amino acid infusion"],"prefix":"10.1371","volume":"21","author":[{"given":"Aryan","family":"Golzaryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9509-1336","authenticated-orcid":true,"given":"Mohammad","family":"Souri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad M.","family":"Kashkooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Rahmim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0878-6274","authenticated-orcid":true,"given":"M.","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"pcbi.1013247.ref001","doi-asserted-by":"crossref","first-page":"100208","DOI":"10.1016\/j.mtbio.2022.100208","article-title":"Towards principled design of cancer nanomedicine to accelerate clinical translation","volume":"13","author":"M Souri","year":"2022","journal-title":"Mater Today Bio"},{"key":"pcbi.1013247.ref002","doi-asserted-by":"crossref","first-page":"114310","DOI":"10.1016\/j.ejpb.2024.114310","article-title":"Charge-Switchable nanoparticles to enhance tumor penetration and accumulation","volume":"199","author":"M Souri","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"pcbi.1013247.ref003","article-title":"Mechanical forces in tumor growth and treatment: perspectives from biology, physics, engineering, and mathematical modeling","volume":"17","author":"F Moradi Kashkooli","year":"2025","journal-title":"WIREs Mech Dis"},{"issue":"12","key":"pcbi.1013247.ref004","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s43588-022-00377-z","article-title":"Mathematical modeling of cancer immunotherapy for personalized clinical translation","volume":"2","author":"JD Butner","year":"2022","journal-title":"Nat Comput Sci"},{"issue":"9","key":"pcbi.1013247.ref005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"G Sgouros","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"pcbi.1013247.ref006","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/0100-3984.2020.0044","article-title":"68Ga-PSMA PET\/CT: effect of external cooling on salivary gland uptake","volume":"54","author":"MZ Junqueira","year":"2021","journal-title":"Radiol Bras"},{"key":"pcbi.1013247.ref007","article-title":"Impact of metronomic radiopharmaceutical therapy on tumor and organ-at-risk absorbed doses: A PBPK modeling approach","volume-title":"European journal of nuclear medicine and molecular imaging","author":"A Golzaryan","year":"2022"},{"issue":"1","key":"pcbi.1013247.ref008","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1038\/s41598-025-86159-9","article-title":"Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling","volume":"15","author":"A Golzaryan","year":"2025","journal-title":"Sci Rep"},{"issue":"18","key":"pcbi.1013247.ref009","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.7150\/thno.77279","article-title":"Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review","volume":"12","author":"H Siebinga","year":"2022","journal-title":"Theranostics"},{"key":"pcbi.1013247.ref010","article-title":"The impact of radiopharmaceutical therapy on renal function","author":"EA Park","year":"2022","journal-title":"Seminars in Nuclear Medicine"},{"key":"pcbi.1013247.ref011","doi-asserted-by":"crossref","DOI":"10.1016\/j.semradonc.2020.07.008","volume-title":"Dosimetry for optimized, personalized radiopharmaceutical therapy","author":"SA Graves","year":"2021"},{"issue":"18","key":"pcbi.1013247.ref012","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.scib.2023.08.009","article-title":"Radiopharmaceutical therapy on-a-chip: a perspective on microfluidic-driven digital twins towards personalized cancer therapies","volume":"68","author":"H Abdollahi","year":"2023","journal-title":"Sci Bull (Beijing)"},{"key":"pcbi.1013247.ref013","doi-asserted-by":"crossref","first-page":"1062592","DOI":"10.3389\/fonc.2022.1062592","article-title":"Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology","volume":"12","author":"A Rahmim","year":"2022","journal-title":"Front Oncol"},{"key":"pcbi.1013247.ref014","volume-title":"Personalized PBPK modeling can reduce uncertainty of the dose prediction in radiopharmaceutical therapy (RPT): a simulation study. 2023 IEEE Nuclear Science Symposium, Medical Imaging Conference and International Symposium on Room-Temperature Semiconductor Detectors (NSS MIC RTSD","author":"R Hu","year":"2023"},{"issue":"6","key":"pcbi.1013247.ref015","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/toxics12060433","article-title":"Recent progress on Physiologically Based Pharmacokinetic (PBPK) model: a review based on bibliometrics","volume":"12","author":"H Huang","year":"2024","journal-title":"Toxics"},{"key":"pcbi.1013247.ref016","first-page":"17","article-title":"Basic principles of PBPK modeling and simulation","volume-title":"The art and science of physiologically-based pharmacokinetics modeling","author":"J Dressman"},{"key":"pcbi.1013247.ref017","doi-asserted-by":"crossref","first-page":"106557","DOI":"10.1016\/j.envint.2021.106557","article-title":"Development and intercomparison of single and multicompartment physiologically-based toxicokinetic models: Implications for model selection and tiered modeling frameworks","volume":"154","author":"JM Armitage","year":"2021","journal-title":"Environ Int"},{"issue":"2","key":"pcbi.1013247.ref018","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10928-017-9559-4","article-title":"A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim","volume":"45","author":"C Niederalt","year":"2018","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"36","key":"pcbi.1013247.ref019","article-title":"Transport barriers influence the activation of anti-tumor immunity: a systems biology analysis","volume":"10","author":"MR Nikmaneshi","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"pcbi.1013247.ref020","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00259-015-3248-6","article-title":"The role of patient-based treatment planning in peptide receptor radionuclide therapy","volume":"43","author":"D Hardiansyah","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"pcbi.1013247.ref021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3413\/Nukmed-0819-16-04","article-title":"Treatment planning in PRRT based on simulated PET data and a PBPK model. Determination of accuracy using a PET noise model","volume":"56","author":"D Hardiansyah","year":"2017","journal-title":"Nuklearmedizin"},{"issue":"6","key":"pcbi.1013247.ref022","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2967\/jnumed.117.203505","article-title":"The Effect of total tumor volume on the biologically effective dose to tumor and kidneys for 177Lu-Labeled PSMA Peptides","volume":"59","author":"NJ Begum","year":"2018","journal-title":"J Nucl Med"},{"key":"pcbi.1013247.ref023","article-title":"Treatment planning algorithm for peptide receptor radionuclide therapy considering multiple tumor lesions and organs at risk","author":"LD Jim\u00e9nez-Franco","year":"2018","journal-title":"Med Phys"},{"issue":"1","key":"pcbi.1013247.ref024","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1208\/s12248-016-0010-3","article-title":"Physiologically Based Pharmacokinetic (PBPK) modeling of pharmaceutical nanoparticles","volume":"19","author":"M Li","year":"2017","journal-title":"AAPS J"},{"issue":"3","key":"pcbi.1013247.ref025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/psp4.12911","article-title":"Investigation of simplified physiologically-based pharmacokinetic models in rat and human","volume":"12","author":"E Yau","year":"2023","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"4","key":"pcbi.1013247.ref026","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s13318-015-0271-8","article-title":"Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model","volume":"41","author":"L Zhu","year":"2016","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"10","key":"pcbi.1013247.ref027","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/psp4.12134","article-title":"Applied Concepts in PBPK Modeling: How to Build a PBPK\/PD Model","volume":"5","author":"L Kuepfer","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"11","key":"pcbi.1013247.ref028","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00228-018-2513-6","article-title":"Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review","volume":"74","author":"T Saeheng","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"pcbi.1013247.ref029","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1208\/s12248-020-00489-2","article-title":"PKPD modeling and dosing considerations in advanced ovarian cancer patients treated with cisplatin-based intraoperative intraperitoneal chemotherapy","volume":"22","author":"F Xie","year":"2020","journal-title":"AAPS J"},{"key":"pcbi.1013247.ref030","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/DDDT.S297981","article-title":"Development and evaluation of a physiologically based pharmacokinetic drug-disease model of propranolol for suggesting model informed dosing in liver cirrhosis patients","volume":"15","author":"MN Kalam","year":"2021","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"pcbi.1013247.ref031","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/cpt.3525","article-title":"Current use of physiologically based pharmacokinetic modeling in new medicinal product approvals at EMA","volume":"117","author":"P Paul","year":"2025","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"pcbi.1013247.ref032","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cpt.539","article-title":"Physiologically based pharmacokinetic modeling in regulatory decision-making at the European Medicines Agency","volume":"102","author":"E Luzon","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"pcbi.1013247.ref033","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/bjh.19410","article-title":"Proof of concept of physiologically based pharmacokinetic modelling in paediatric acute lymphoblastic leukaemia","volume":"204","author":"T Bauch","year":"2024","journal-title":"Br J Haematol"},{"issue":"6","key":"pcbi.1013247.ref034","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/pharmaceutics12060578","article-title":"Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates","volume":"12","author":"L Kovar","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"pcbi.1013247.ref035","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s11095-024-03725-y","article-title":"A Combination of Machine Learning and PBPK Modeling Approach for Pharmacokinetics Prediction of Small Molecules in Humans","volume":"41","author":"Y Li","year":"2024","journal-title":"Pharm Res"},{"issue":"6","key":"pcbi.1013247.ref036","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1208\/s12248-017-0131-3","article-title":"Development of a Translational Physiologically Based Pharmacokinetic Model for Antibody-Drug Conjugates: a Case Study with T-DM1","volume":"19","author":"A Khot","year":"2017","journal-title":"AAPS J"},{"issue":"5","key":"pcbi.1013247.ref037","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10928-021-09772-x","article-title":"Two-pore physiologically based pharmacokinetic model validation using whole-body biodistribution of trastuzumab and different-size fragments in mice","volume":"48","author":"Z Li","year":"2021","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"5","key":"pcbi.1013247.ref038","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10928-024-09922-x","article-title":"Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteins","volume":"51","author":"S Liu","year":"2024","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"2","key":"pcbi.1013247.ref039","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/pr.119.018101","article-title":"Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids","volume":"72","author":"VS Ayyar","year":"2020","journal-title":"Pharmacol Rev"},{"key":"pcbi.1013247.ref040","doi-asserted-by":"crossref","first-page":"1272091","DOI":"10.3389\/fphar.2023.1272091","article-title":"A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis","volume":"14","author":"F Reali","year":"2024","journal-title":"Front Pharmacol"},{"issue":"23","key":"pcbi.1013247.ref041","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ifacol.2024.10.014","article-title":"Modeling principles for a physiology-based whole-body model of human metabolism","volume":"58","author":"LH Blicher","year":"2024","journal-title":"IFAC-PapersOnLine"},{"issue":"9","key":"pcbi.1013247.ref042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162303","article-title":"Investigating the effect of ligand amount and injected therapeutic activity: a simulation study for 177Lu-Labeled PSMA-targeting peptides","volume":"11","author":"P Kletting","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"pcbi.1013247.ref043","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2967\/jnumed.115.164699","article-title":"Optimized peptide amount and activity for \u2079\u2070Y-Labeled DOTATATE therapy","volume":"57","author":"P Kletting","year":"2016","journal-title":"J Nucl Med"},{"key":"pcbi.1013247.ref044","volume-title":"The effect of the total tumour volume on the kidneys, salivary glands and tumour beds for Lu-177-labelled PSMA ligands","author":"N Begum"},{"key":"pcbi.1013247.ref045","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmp.2017.06.024","article-title":"Prediction of time-integrated activity coefficients in PRRT using simulated dynamic PET and a pharmacokinetic model","volume":"42","author":"D Hardiansyah","year":"2017","journal-title":"Phys Med"},{"key":"pcbi.1013247.ref046","doi-asserted-by":"crossref","first-page":"964049","DOI":"10.3389\/fphar.2022.964049","article-title":"A compatibility evaluation between the physiologically based pharmacokinetic (PBPK) model and the compartmental PK model using the lumping method with real cases","volume":"13","author":"j Ryu H","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"pcbi.1013247.ref047","first-page":"1","article-title":"A whole-body mechanistic physiologically-based pharmacokinetic modeling of intravenous iron","author":"X Fan","year":"2024","journal-title":"Drug Delivery and Translational Research"},{"key":"pcbi.1013247.ref048","article-title":"Whole-body Bacteriophage Distribution Characterized by a Physiologically based Pharmacokinetic Model","author":"A Echterhof","year":"2025","journal-title":"bioRxiv"},{"issue":"5","key":"pcbi.1013247.ref049","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1208\/s12248-022-00732-y","article-title":"Determination of the number of tissue groups of kinetically distinct transit time in whole-body Physiologically Based Pharmacokinetic (PBPK) Models I: Theoretical Consideration of Bottom-Up Approach of Lumping Tissues in Whole-Body PBPK","volume":"24","author":"Y-S Jeong","year":"2022","journal-title":"AAPS J"},{"issue":"2","key":"pcbi.1013247.ref050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/toxics11020126","article-title":"An overview of physiologically-based pharmacokinetic models for forensic science","volume":"11","author":"K Fairman","year":"2023","journal-title":"Toxics"},{"key":"pcbi.1013247.ref051","doi-asserted-by":"crossref","first-page":"1518769","DOI":"10.3389\/ftox.2025.1518769","article-title":"Comparing computational times for simulations when using PBPK model template and stand-alone implementations of PBPK models","volume":"7","author":"AS Bernstein","year":"2025","journal-title":"Front Toxicol"},{"issue":"5","key":"pcbi.1013247.ref052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127934","article-title":"Physiologically based pharmacokinetic modeling is essential in 90Y-Labeled Anti-CD66 radioimmunotherapy","volume":"10","author":"P Kletting","year":"2015","journal-title":"PLoS One"},{"key":"pcbi.1013247.ref053","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/907461","article-title":"Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development","volume":"2011","author":"F Khalil","year":"2011","journal-title":"BioMed Research International"},{"issue":"1","key":"pcbi.1013247.ref054","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1208\/s12248-009-9088-1","article-title":"Modelling and PBPK simulation in drug discovery","volume":"11","author":"HM Jones","year":"2009","journal-title":"AAPS J"},{"key":"pcbi.1013247.ref055","doi-asserted-by":"crossref","first-page":"108004","DOI":"10.1016\/j.cmpb.2023.108004","article-title":"Spatiotemporal modeling of radiopharmaceutical transport in solid tumors: Application to 177Lu-PSMA therapy of prostate cancer","volume":"245","author":"A Piranfar","year":"2024","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"pcbi.1013247.ref056","doi-asserted-by":"crossref","first-page":"14582","DOI":"10.1038\/s41598-022-18723-6","article-title":"Spatiotemporal multi-scale modeling of radiopharmaceutical distributions in vascularized solid tumors","volume":"12","author":"M Kiani Shahvandi","year":"2022","journal-title":"Sci Rep"},{"key":"pcbi.1013247.ref057","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4614-0052-3_5","article-title":"A hybrid discrete-continuum model of tumour induced angiogenesis","volume-title":"Modeling tumor vasculature: molecular, cellular, and tissue level aspects and implications","author":"AR Anderson","year":"2012"},{"issue":"5","key":"pcbi.1013247.ref058","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1006\/bulm.1998.0042","article-title":"Continuous and discrete mathematical models of tumor-induced angiogenesis","volume":"60","author":"AR Anderson","year":"1998","journal-title":"Bull Math Biol"},{"issue":"6","key":"pcbi.1013247.ref059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009081","article-title":"Multiscale modeling of tumor growth and angiogenesis: Evaluation of tumor-targeted therapy","volume":"17","author":"S Jafari Nivlouei","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"pcbi.1013247.ref060","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s00432-021-03814-0","article-title":"3D tumor angiogenesis models: recent advances and challenges","volume":"147","author":"SM Bhat","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"pcbi.1013247.ref061","doi-asserted-by":"crossref","first-page":"167028","DOI":"10.1016\/j.bbadis.2024.167028","article-title":"2D and 3D in vitro angiogenesis assays highlight different aspects of angiogenesis","volume":"1870","author":"J Rapp","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"8","key":"pcbi.1013247.ref062","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jcmm.12164","article-title":"A systems biology view of blood vessel growth and remodelling","volume":"18","author":"EA Logsdon","year":"2014","journal-title":"J Cell Mol Med"},{"key":"pcbi.1013247.ref063","doi-asserted-by":"crossref","first-page":"0006","DOI":"10.34133\/bmef.0006","article-title":"Challenges and opportunities modeling the dynamic tumor matrisome","volume":"4","author":"SR Peyton","year":"2023","journal-title":"BME Front"},{"key":"pcbi.1013247.ref064","doi-asserted-by":"crossref","first-page":"134690","DOI":"10.1016\/j.cej.2022.134690","article-title":"1D, 2D, and 3D scaffolds promoting angiogenesis for enhanced wound healing","volume":"437","author":"Y Guo","year":"2022","journal-title":"Chemical Engineering Journal"},{"issue":"1","key":"pcbi.1013247.ref065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083962","article-title":"Computational modeling of 3D tumor growth and angiogenesis for chemotherapy evaluation","volume":"9","author":"L Tang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"pcbi.1013247.ref066","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/s41598-020-59658-0","article-title":"A multi-scale model for determining the effects of pathophysiology and metabolic disorders on tumor growth","volume":"10","author":"MR Nikmaneshi","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"pcbi.1013247.ref067","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011740","article-title":"Mathematical modeling of intratumoral immunotherapy yields strategies to improve the treatment outcomes","volume":"19","author":"C Harkos","year":"2023","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"pcbi.1013247.ref068","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.mcm.2005.05.008","article-title":"Mathematical modelling of flow in 2D and 3D vascular networks: Applications to anti-angiogenic and chemotherapeutic drug strategies","volume":"41","author":"A St\u00e9phanou","year":"2005","journal-title":"Mathematical and Computer Modelling"},{"issue":"2","key":"pcbi.1013247.ref069","doi-asserted-by":"crossref","DOI":"10.1002\/cso2.1018","article-title":"Biomechanical modelling of cancer: Agent-based force-based models of solid tumours within the context of the tumour microenvironment","volume":"1","author":"CK Macnamara","year":"2021","journal-title":"Comp Sys Onco"},{"issue":"1","key":"pcbi.1013247.ref070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009499","article-title":"Towards integration of time-resolved confocal microscopy of a 3D in vitro microfluidic platform with a hybrid multiscale model of tumor angiogenesis","volume":"19","author":"CM Phillips","year":"2023","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"pcbi.1013247.ref071","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pbiomolbio.2011.06.006","article-title":"The role of the microenvironment in tumor growth and invasion","volume":"106","author":"Y Kim","year":"2011","journal-title":"Prog Biophys Mol Biol"},{"issue":"1","key":"pcbi.1013247.ref072","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","article-title":"The clinical role of the TME in solid cancer","volume":"120","author":"NA Giraldo","year":"2019","journal-title":"Br J Cancer"},{"issue":"4","key":"pcbi.1013247.ref073","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/cells10040831","article-title":"Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer","volume":"10","author":"T Ho","year":"2021","journal-title":"Cells"},{"issue":"22","key":"pcbi.1013247.ref074","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1158\/0008-5472.CAN-14-2945","article-title":"Predicting the response of breast cancer to neoadjuvant therapy using a mechanically coupled reaction-diffusion model","volume":"75","author":"JA Weis","year":"2015","journal-title":"Cancer Res"},{"issue":"12","key":"pcbi.1013247.ref075","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1109\/TBME.2021.3085523","article-title":"Modeling of glioma growth with mass effect by longitudinal magnetic resonance imaging","volume":"68","author":"B Tunc","year":"2021","journal-title":"IEEE Trans Biomed Eng"},{"issue":"11","key":"pcbi.1013247.ref076","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1109\/TBME.2022.3168402","article-title":"Towards patient-specific optimization of neoadjuvant treatment protocols for breast cancer based on image-guided fluid dynamics","volume":"69","author":"C Wu","year":"2022","journal-title":"IEEE Trans Biomed Eng"},{"issue":"2","key":"pcbi.1013247.ref077","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/nano9020167","article-title":"Prediction of gold nanoparticle and microwave-induced hyperthermia effects on tumor control via a simulation approach","volume":"9","author":"NM Dimitriou","year":"2019","journal-title":"Nanomaterials (Basel)"},{"issue":"4","key":"pcbi.1013247.ref078","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrclinonc.2015.204","article-title":"Computational oncology--mathematical modelling of drug regimens for precision medicine","volume":"13","author":"D Barbolosi","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"pcbi.1013247.ref079","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/pr7010037","article-title":"Multiscale agent-based and hybrid modeling of the tumor immune microenvironment","volume":"7","author":"K-A Norton","year":"2019","journal-title":"Processes (Basel)"},{"issue":"1","key":"pcbi.1013247.ref080","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1461","article-title":"Hybrid modeling frameworks of tumor development and treatment","volume":"12","author":"IM Chamseddine","year":"2020","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"8","key":"pcbi.1013247.ref081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183810","article-title":"Hybrid multiscale modeling and prediction of cancer cell behavior","volume":"12","author":"MH Zangooei","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"pcbi.1013247.ref082","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11538-024-01286-0","article-title":"A genuinely hybrid, multiscale 3d cancer invasion and metastasis modelling framework","volume":"86","author":"D Katsaounis","year":"2024","journal-title":"Bull Math Biol"},{"issue":"4","key":"pcbi.1013247.ref083","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10237-022-01587-0","article-title":"Investigation of cancer response to chemotherapy: a hybrid multi-scale mathematical and computational model of the tumor microenvironment","volume":"21","author":"MR Nikmaneshi","year":"2022","journal-title":"Biomech Model Mechanobiol"},{"issue":"11","key":"pcbi.1013247.ref084","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.3934\/mbe.2024335","article-title":"Agent-based modeling for the tumor microenvironment (TME)","volume":"21","author":"HN Weerasinghe","year":"2024","journal-title":"Math Biosci Eng"},{"issue":"11","key":"pcbi.1013247.ref085","article-title":"Bayesian calibration of a stochastic, multiscale agent-based model for predicting in vitro tumor growth","volume":"17","author":"EABF Lima","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"8","key":"pcbi.1013247.ref086","article-title":"Mathematical modelling reveals cellular dynamics within tumour spheroids","volume":"16","author":"JA Bull","year":"2020","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"pcbi.1013247.ref087","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012112","article-title":"Cancer cell sedimentation in 3D cultures reveals active migration regulated by self-generated gradients and adhesion sites","volume":"20","author":"NM Dimitriou","year":"2024","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"pcbi.1013247.ref088","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1109\/TBME.2022.3216231","article-title":"Quantifying the Morphology and Mechanisms of Cancer Progression in 3D In-Vitro Environments: Integrating Experiments and Multiscale Models","volume":"70","author":"NM Dimitriou","year":"2023","journal-title":"IEEE Trans Biomed Eng"},{"key":"pcbi.1013247.ref089","doi-asserted-by":"crossref","first-page":"647031","DOI":"10.3389\/fbioe.2021.647031","article-title":"Engineering a Vascularized 3D Hybrid System to Model Tumor-Stroma Interactions in Breast Cancer","volume":"9","author":"FC Teixeira","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"pcbi.1013247.ref090","doi-asserted-by":"crossref","first-page":"12373","DOI":"10.1038\/s41598-022-15767-6","article-title":"Integrating a dynamic central metabolism model of cancer cells with a hybrid 3D multiscale model for vascular hepatocellular carcinoma growth","volume":"12","author":"A Lapin","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"pcbi.1013247.ref091","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13577-021-00642-9","article-title":"3D modeling in cancer studies","volume":"35","author":"OE Atat","year":"2022","journal-title":"Hum Cell"},{"issue":"5","key":"pcbi.1013247.ref092","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41568-025-00796-w","article-title":"Using mathematical modelling and AI to improve delivery and efficacy of therapies in cancer","volume":"25","author":"C Harkos","year":"2025","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"pcbi.1013247.ref093","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s41181-024-00251-5","article-title":"Correction: Physiologically based radiopharmacokinetic (PBRPK) modeling to simulate and analyze radiopharmaceutical therapies: studies of non-linearities, multi-bolus injections, and albumin binding","volume":"9","author":"A Fele-Paranj","year":"2024","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"1","key":"pcbi.1013247.ref094","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41540-024-00362-4","article-title":"Radiopharmaceutical transport in solid tumors via a 3-dimensional image-based spatiotemporal model","volume":"10","author":"A Piranfar","year":"2024","journal-title":"NPJ Syst Biol Appl"},{"issue":"1","key":"pcbi.1013247.ref095","doi-asserted-by":"crossref","first-page":"20041","DOI":"10.1038\/s41598-019-56603-8","article-title":"The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK model","volume":"9","author":"NJ Begum","year":"2019","journal-title":"Sci Rep"},{"key":"pcbi.1013247.ref096","article-title":"Single-time-point renal dosimetry using nonlinear mixed-effects modeling and population-based model selection in [177Lu] Lu-PSMA-617 Therapy","author":"D Hardiansyah","year":"2024","journal-title":"Journal of Nuclear Medicine"},{"issue":"9","key":"pcbi.1013247.ref097","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1118\/1.4747266","article-title":"Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy","volume":"39","author":"P Kletting","year":"2012","journal-title":"Med Phys"},{"key":"pcbi.1013247.ref098","article-title":"Pharmacokinetic analysis of 177Lu-DOTATATE using mixed model across treatment cycles","author":"A Akhavanallaf","year":"2024","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"1","key":"pcbi.1013247.ref099","doi-asserted-by":"crossref","first-page":"2186312","DOI":"10.1080\/10717544.2023.2186312","article-title":"Stimuli-sensitive nano-drug delivery with programmable size changes to enhance accumulation of therapeutic agents in tumors","volume":"30","author":"M Souri","year":"2023","journal-title":"Drug Deliv"},{"issue":"1","key":"pcbi.1013247.ref100","doi-asserted-by":"crossref","first-page":"19350","DOI":"10.1038\/s41598-021-98638-w","article-title":"Effects of hypoxia and nanocarrier size on pH-responsive nano-delivery system to solid tumors","volume":"11","author":"M Soltani","year":"2021","journal-title":"Sci Rep"},{"issue":"14","key":"pcbi.1013247.ref101","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.3390\/cancers13143429","article-title":"Is hypoxia a factor influencing psma-directed radioligand therapy?-an in silico study on the role of chronic hypoxia in prostate cancer","volume":"13","author":"G Birindelli","year":"2021","journal-title":"Cancers (Basel)"},{"key":"pcbi.1013247.ref102","volume-title":"Comparative analysis of chelator-modified peptides for imaging of prostate carcinoma","author":"G Winter","year":"2014"},{"issue":"8","key":"pcbi.1013247.ref103","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2967\/jnumed.115.158550","article-title":"68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies","volume":"56","author":"M Weineisen","year":"2015","journal-title":"J Nucl Med"},{"key":"pcbi.1013247.ref104","volume-title":"Comprehensive modeling of the spatiotemporal distribution of PET tracer uptake in solid tumors based on the Convection-Diffusion-Reaction equation. 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS\/MIC","author":"M Soltani","year":"2014"},{"key":"pcbi.1013247.ref105","doi-asserted-by":"crossref","unstructured":"Strisciuglio N, Azzopardi G, Vento M, Petkov N, editors. Multiscale blood vessel delineation using B-COSFIRE filters. Computer Analysis of Images and Patterns: 16th International Conference, CAIP 2015, Valletta, Malta, September 2-4, 2015, Proceedings, Part II 16; 2015: Springer.","DOI":"10.1007\/978-3-319-23117-4"},{"key":"pcbi.1013247.ref106","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mvr.2015.02.007","article-title":"Numerical modeling of drug delivery in a dynamic solid tumor microvasculature","volume":"99","author":"M Sefidgar","year":"2015","journal-title":"Microvasc Res"},{"issue":"6","key":"pcbi.1013247.ref107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020344","article-title":"Numerical modeling of fluid flow in solid tumors","volume":"6","author":"M Soltani","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"pcbi.1013247.ref108","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0026-2862(89)90074-5","article-title":"Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection","volume":"37","author":"LT Baxter","year":"1989","journal-title":"Microvasc Res"},{"key":"pcbi.1013247.ref109","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1201\/9780429399039-10","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","volume-title":"Nano-Enabled Medical Applications","author":"VP Chauhan","year":"2020"},{"key":"pcbi.1013247.ref110","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2017.12.020","article-title":"Convection enhanced delivery of chemotherapeutic drugs into brain tumour","volume":"271","author":"W Zhan","year":"2018","journal-title":"J Control Release"},{"issue":"5","key":"pcbi.1013247.ref111","article-title":"A finite element model for predicting the distribution of drugs delivered intracranially to the brain","volume":"273","author":"S Kalyanasundaram","year":"1997","journal-title":"Am J Physiol"},{"issue":"1","key":"pcbi.1013247.ref112","doi-asserted-by":"crossref","first-page":"19539","DOI":"10.1038\/s41598-021-98554-z","article-title":"Computational modeling of thermal combination therapies by magneto-ultrasonic heating to enhance drug delivery to solid tumors","volume":"11","author":"M Souri","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"pcbi.1013247.ref113","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2009.04.013","article-title":"Chemotherapeutic drug transport to brain tumor","volume":"137","author":"DY Arifin","year":"2009","journal-title":"J Control Release"},{"issue":"2","key":"pcbi.1013247.ref114","first-page":"113","article-title":"A comparison of 2D and 3D kidney absorbed dose measures in patients receiving 177Lu-DOTATATE","volume":"6","author":"KP Willowson","year":"2018","journal-title":"Asia Ocean J Nucl Med Biol"},{"issue":"1","key":"pcbi.1013247.ref115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40658-022-00497-5","article-title":"Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model","volume":"9","author":"J Tranel","year":"2022","journal-title":"EJNMMI Phys"},{"issue":"3","key":"pcbi.1013247.ref116","first-page":"538","article-title":"MIRDOSE: personal computer software for internal dose assessment in nuclear medicine","volume":"37","author":"MG Stabin","year":"1996","journal-title":"J Nucl Med"},{"key":"pcbi.1013247.ref117","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/978-1-4612-4380-9_16","article-title":"Individual comparisons by ranking methods","volume-title":"Breakthroughs in statistics: Methodology and distribution","author":"F Wilcoxon","year":"1992"},{"issue":"2","key":"pcbi.1013247.ref118","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ccc.2019.12.011","article-title":"A Review on Microvascular Hemodynamics: The Control of Blood Flow Distribution and Tissue Oxygenation","volume":"36","author":"CJ Munoz","year":"2020","journal-title":"Crit Care Clin"},{"issue":"10","key":"pcbi.1013247.ref119","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/nm.1971","article-title":"Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging","volume":"15","author":"BJ Vakoc","year":"2009","journal-title":"Nat Med"},{"issue":"18","key":"pcbi.1013247.ref120","first-page":"5110","article-title":"Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse","volume":"52","author":"Y Boucher","year":"1992","journal-title":"Cancer research"},{"issue":"5","key":"pcbi.1013247.ref121","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s10439-010-9957-x","article-title":"Poroviscoelastic modeling of liver biomechanical response in unconfined compression","volume":"38","author":"S Raghunathan","year":"2010","journal-title":"Ann Biomed Eng"},{"issue":"4","key":"pcbi.1013247.ref122","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.trecan.2018.02.005","article-title":"Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: from mathematical modeling to bench to bedside","volume":"4","author":"T Stylianopoulos","year":"2018","journal-title":"Trends Cancer"},{"issue":"1","key":"pcbi.1013247.ref123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2967\/jnmt.107.046839","article-title":"SPECT\/CT physical principles and attenuation correction","volume":"36","author":"JA Patton","year":"2008","journal-title":"J Nucl Med Technol"},{"issue":"2","key":"pcbi.1013247.ref124","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.nuclcard.2007.01.037","article-title":"Attenuation artifact, attenuation correction, and the future of myocardial perfusion SPECT","volume":"14","author":"B Singh","year":"2007","journal-title":"J Nucl Cardiol"},{"key":"pcbi.1013247.ref125","first-page":"83","article-title":"A technique for using CT images in attenuation correction and quantification in SPECT","volume-title":"LWW","author":"J Fleming","year":"1989"},{"issue":"6","key":"pcbi.1013247.ref126","first-page":"1278","article-title":"Attenuation and scatter correction in SPECT for sources in a nonhomogeneous object: a monte Carlo study","volume":"32","author":"M Ljungberg","year":"1991","journal-title":"J Nucl Med"},{"issue":"2","key":"pcbi.1013247.ref127","first-page":"181","article-title":"An overview of attenuation and scatter correction of planar and SPECT data for dosimetry studies","volume":"18","author":"M King","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"issue":"12","key":"pcbi.1013247.ref128","first-page":"1861","article-title":"Generalized scatter correction method in SPECT using point scatter distribution functions","volume":"28","author":"P Msaki","year":"1987","journal-title":"J Nucl Med"},{"key":"pcbi.1013247.ref129","doi-asserted-by":"crossref","DOI":"10.1016\/j.nima.2010.12.106","article-title":"Partial volume correction in SPECT reconstruction with OSEM","volume":"648","author":"K Erlandsson","year":"2011","journal-title":"Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment"},{"issue":"21","key":"pcbi.1013247.ref130","doi-asserted-by":"crossref","DOI":"10.1088\/0031-9155\/57\/21\/R119","article-title":"A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology","volume":"57","author":"K Erlandsson","year":"2012","journal-title":"Phys Med Biol"},{"key":"pcbi.1013247.ref131","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/0-387-25444-7_8","article-title":"Correction for partial volume effects in emission tomography","volume-title":"Quantitative Analysis in Nuclear Medicine Imaging","author":"OG Rousset","year":"2006"},{"key":"pcbi.1013247.ref132","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00259-018-4209-7","article-title":"Personalized 177 Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial","volume":"46","author":"M Del Prete","year":"2019","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"16","key":"pcbi.1013247.ref133","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.3390\/molecules27165231","article-title":"Radiopharmaceutical Treatments for Cancer Therapy, Radionuclides Characteristics, Applications, and Challenges","volume":"27","author":"S Salih","year":"2022","journal-title":"Molecules"},{"key":"pcbi.1013247.ref134","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1218670","article-title":"Developments in 177Lu-based radiopharmaceutical therapy and dosimetry","volume":"11","author":"SC George","year":"2023","journal-title":"Frontiers in Chemistry"},{"issue":"4","key":"pcbi.1013247.ref135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.035","article-title":"Current Status of Radiopharmaceutical Therapy","volume":"109","author":"S St James","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"pcbi.1013247.ref136","doi-asserted-by":"crossref","DOI":"10.1016\/j.semradonc.2023.03.011","article-title":"Theranostics and patient-specific dosimetry","volume-title":"Seminars in Radiation Oncology","author":"B Bednarz","year":"2023"},{"issue":"10","key":"pcbi.1013247.ref137","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/ar200019c","article-title":"Theranostic nanomedicine","volume":"44","author":"T Lammers","year":"2011","journal-title":"Acc Chem Res"},{"issue":"8","key":"pcbi.1013247.ref138","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s11095-022-03274-2","article-title":"Applications, Challenges, and Outlook for PBPK Modeling and Simulation: A Regulatory, Industrial and Academic Perspective","volume":"39","author":"W Lin","year":"2022","journal-title":"Pharm Res"},{"key":"pcbi.1013247.ref139","doi-asserted-by":"crossref","first-page":"101057","DOI":"10.1016\/j.nantod.2020.101057","article-title":"Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine","volume":"36","author":"F Moradi Kashkooli","year":"2021","journal-title":"Nano Today"},{"key":"pcbi.1013247.ref140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2020.08.012","article-title":"Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies","volume":"327","author":"F Moradi Kashkooli","year":"2020","journal-title":"J Control Release"},{"issue":"1","key":"pcbi.1013247.ref141","doi-asserted-by":"crossref","first-page":"2219871","DOI":"10.1080\/10717544.2023.2219871","article-title":"A spatiotemporal computational model of focused ultrasound heat-induced nano-sized drug delivery system in solid tumors","volume":"30","author":"F Moradi Kashkooli","year":"2023","journal-title":"Drug Deliv"},{"key":"pcbi.1013247.ref142","article-title":"An in silico study quantifying the effects of reducing salivary gland blood flow on tumor to organ-at-risk absorbed dose ratios","author":"A Golzaryan","year":"2023","journal-title":"Soc Nuclear Med"},{"issue":"31","key":"pcbi.1013247.ref143","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/D0TB00649A","article-title":"Overcoming the biological barriers in the tumor microenvironment for improving drug delivery and efficacy","volume":"8","author":"Y Zhou","year":"2020","journal-title":"J Mater Chem B"},{"issue":"15","key":"pcbi.1013247.ref144","first-page":"4478","article-title":"Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy","volume":"50","author":"Y Boucher","year":"1990","journal-title":"Cancer Res"},{"issue":"6","key":"pcbi.1013247.ref145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009164","article-title":"Simulation of angiogenesis in three dimensions: Application to cerebral cortex","volume":"17","author":"JP Alberding","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"pcbi.1013247.ref146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002983","article-title":"Angiogenesis: an adaptive dynamic biological patterning problem","volume":"9","author":"TW Secomb","year":"2013","journal-title":"PLoS Comput Biol"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1013247","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013247","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T17:49:49Z","timestamp":1754502589000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013247"}},"subtitle":[],"editor":[{"given":"James","family":"Gallo,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":146,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1013247","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}